NAUT News and Press, Nautilus Biotechnology Inc. From 11/30/23

SEATTLE, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced Nautilus co-founder and Chief Scientist Parag Mallick, Ph.D., was sel...

SEATTLE, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the expansion of its research and development senior leadership team ...

2023-10-31 11:22:10 ET Nautilus Biotechnology, Inc. (NAUT) Q3 2023 Earnings Conference Call October 31, 2023, 8:30 am ET Company Participants Carrie Mendivil - IR Sujal Patel - Co-Founder & CEO Parag Mallick - Co-Founder & Chief Scientist Anna Mowry -...

2023-10-31 09:05:22 ET More on Nautilus Biotechnology Nautilus Biotechnology: Trades At Net-Cash And Investment Value With Proteomics Upside Nautilus Biotechnology, Inc. (NAUT) Q2 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Nautilus Biotechno...

SEATTLE, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial results for the third quarter ended September 30, 2023. “I’m ve...

Tennant Company (TNC) is expected to report for Q3 2023 Stellantis N.V. (STLA) is expected to report for Q3 2023 Marathon Petroleum Corporation (MPC) is expected to report $7.79 for Q3 2023 Easterly Government Properties Inc. (DEA) is expected to report $0.29 for Q3 2023 Allegion ...

Nautilus Biotechnology Inc. (NAUT) is expected to report $-0.18 for Q3 2023

2023-10-23 07:23:28 ET Summary Nautilus Biotechnology is developing a molecule protein fingerprinting system with applications in pharmaceutical development and diagnostics. They have important patents. The potential market size for Nautilus is conservatively estimated to be aroun...

SEATTLE, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the third quarter before market open on Tuesday, October 31, ...

2023-09-28 17:12:16 ET Gainers: Editas Medicine ( NASDAQ: EDIT ) +8% . Marqeta ( MQ ) +3% . Cipher Mining ( CIFR ) +3% . Aclaris Therapeutics ( ACRS ) +2% . Biora Therapeutics ( BIOR ) +2% . Losers: Jaguar Global Grow...